D. E. Shaw & Co., Inc. Hookipa Pharma Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.33 - $2.31 $51,951 - $90,230	-39,061 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.26 - $2.52 $29,489 - $58,978	23,404 Added 149.48%	39,061 $89,000
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.94 $1,379 - $3,516	-592 Reduced 3.64%	15,657 $36,000
Q3 2021 Nov 15, 2021	SELL	$5.89 - $9.35 $2,573 - $4,085	-437 Reduced 2.62%	16,249 $96,000
Q2 2021 Aug 16, 2021	BUY	$9.16 - $19.51 $152,843 - $325,543	16,686 New	16,686 $153,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $106M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.